2021 Q2 Form 10-Q Financial Statement

#000110465921108647 Filed on August 23, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q4
Revenue $0.00
YoY Change
Cost Of Revenue $3.755M
YoY Change
Gross Profit $15.57M
YoY Change
Gross Profit Margin
Selling, General & Admin $2.034M
YoY Change
% of Gross Profit 13.06%
Research & Development $5.983M
YoY Change
% of Gross Profit 38.42%
Depreciation & Amortization $3.792M
YoY Change
% of Gross Profit 24.35%
Operating Expenses $2.034M
YoY Change
Operating Profit -$2.034M
YoY Change
Interest Expense $3.990M
YoY Change
% of Operating Profit
Other Income/Expense, Net $5.930K
YoY Change
Pretax Income $1.961M
YoY Change
Income Tax -$2.556M
% Of Pretax Income -130.31%
Net Earnings $1.961M
YoY Change
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $89.67K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q2 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $23.53K
YoY Change
Cash & Equivalents $23.53K $0.00
Short-Term Investments
Other Short-Term Assets $535.5K
YoY Change
Inventory
Prepaid Expenses $535.5K $789.8K
Receivables
Other Receivables
Total Short-Term Assets $559.0K $1.201M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill $120.7M
YoY Change
Intangibles
YoY Change
Long-Term Investments $175.1M
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $175.1M $175.0M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $559.0K $1.201M
Total Long-Term Assets $175.1M $175.0M
Total Assets $175.6M $176.2M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.684M $4.291K
YoY Change
Accrued Expenses $318.0K $179.8K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.002M $359.7K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $19.24M
YoY Change
Total Long-Term Liabilities $19.24M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.002M $359.7K
Total Long-Term Liabilities $19.24M
Total Liabilities $21.24M $27.29M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$20.60M -$26.06M
YoY Change
Common Stock $256.00 $311.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$20.60M -$26.06M
YoY Change
Total Liabilities & Shareholders Equity $175.6M $176.2M
YoY Change

Cashflow Statement

Concept 2021 Q2 2020 Q4
OPERATING ACTIVITIES
Net Income $1.961M
YoY Change
Depreciation, Depletion And Amortization $3.792M
YoY Change
Cash From Operating Activities -$36.12K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures -$1.379M
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$21.56M
YoY Change
Cash From Investing Activities -$22.94M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -88.21K
YoY Change
NET CHANGE
Cash From Operating Activities -36.12K
Cash From Investing Activities -22.94M
Cash From Financing Activities -88.21K
Net Change In Cash -124.3K
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$36.12K
Capital Expenditures -$1.379M
Free Cash Flow $1.343M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 dsac Net Income Allocable To Class A Common Stock Subject To Possible Redemption
NetIncomeAllocableToClassACommonStockSubjectToPossibleRedemption
5061
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39672
dei Amendment Flag
AmendmentFlag
false
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
dsac Threshold Business Days For Redemption Of Public Shares
ThresholdBusinessDaysForRedemptionOfPublicShares
P10D
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
dei Entity Central Index Key
EntityCentralIndexKey
0001823466
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Registrant Name
EntityRegistrantName
DUDDELL STREET ACQUISITION CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
dei Entity Address Address Line1
EntityAddressAddressLine1
8/F Printing House
dei Entity Address Address Line2
EntityAddressAddressLine2
6 Duddell Street
dei Entity Address Country
EntityAddressCountry
HK
dei City Area Code
CityAreaCode
852 3468 6200
dei Local Phone Number
LocalPhoneNumber
852
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2021Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
535450
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
5000010
dsac Net Income Allocable To Class A Common Stock Subject To Possible Redemption
NetIncomeAllocableToClassACommonStockSubjectToPossibleRedemption
43922
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
5000002
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23534
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
789798
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q2 us-gaap Assets Current
AssetsCurrent
558984
CY2020Q4 us-gaap Assets Current
AssetsCurrent
1201490
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
256
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
311
CY2021Q2 dsac Common Stock Value1
CommonStockValue1
437
CY2020Q4 dsac Common Stock Value1
CommonStockValue1
437
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8628540
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
14090096
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3629223
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9090842
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0
CY2021Q2 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
0
CY2020Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
411692
CY2021Q2 us-gaap Assets Held In Trust
AssetsHeldInTrust
175082137
CY2020Q4 us-gaap Assets Held In Trust
AssetsHeldInTrust
175030689
CY2021Q2 us-gaap Assets
Assets
175641121
CY2020Q4 us-gaap Assets
Assets
176232179
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1683984
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4291
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
318037
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
179780
CY2021Q2 us-gaap Notes Payable Current
NotesPayableCurrent
0
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
175626
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
2002021
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
359697
CY2021Q2 us-gaap Deferred Income Noncurrent
DeferredIncomeNoncurrent
6125000
CY2020Q4 us-gaap Deferred Income Noncurrent
DeferredIncomeNoncurrent
6125000
CY2021Q2 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
13110000
CY2020Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
20805000
CY2021Q2 us-gaap Liabilities
Liabilities
21237021
CY2020Q4 us-gaap Liabilities
Liabilities
27289697
CY2021Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
149404090
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
143942480
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
175641121
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
176232179
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2034461
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2284830
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2034461
us-gaap Operating Income Loss
OperatingIncomeLoss
-2284830
CY2021Q2 dsac Redeem Shares
RedeemShares
10.00
CY2021Q2 us-gaap Assets Net
AssetsNet
5000001
CY2021Q2 dsac Nonredeemable Net Loss
NonredeemableNetLoss
1956406
dsac Nonredeemable Net Loss
NonredeemableNetLoss
5417697
CY2021Q2 us-gaap Restricted Investments Percent Of Net Assets
RestrictedInvestmentsPercentOfNetAssets
0.20
CY2021Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3990000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-7695000
dsac Percentage Obligation To Redeem Public Shares If Entity Does Not Complete Business Combination
PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination
1
dsac Dissolution Expenses
DissolutionExpenses
100000
CY2021Q2 us-gaap Interest Income Other
InterestIncomeOther
5928
us-gaap Interest Income Other
InterestIncomeOther
51449
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
1961467
us-gaap Net Income Loss
NetIncomeLoss
5461619
CY2021Q2 dsac Weighted Average Shares Outstanding Of Ordinary Shares Subject To Redemption Basic And Diluted
WeightedAverageSharesOutstandingOfOrdinarySharesSubjectToRedemptionBasicAndDiluted
14746418
dsac Weighted Average Shares Outstanding Of Ordinary Shares Subject To Redemption Basic And Diluted
WeightedAverageSharesOutstandingOfOrdinarySharesSubjectToRedemptionBasicAndDiluted
14573240
CY2021Q2 dsac Basic And Diluted Net Income Per Share Ordinary Shares Subject To Redemptions
BasicAndDilutedNetIncomePerShareOrdinarySharesSubjectToRedemptions
0.00
CY2021Q2 dsac Basic And Diluted Weighted Average Shares Outstanding Non Redeemable Common Stock In Shares
BasicAndDilutedWeightedAverageSharesOutstandingNonRedeemableCommonStockInShares
7128582
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
147860
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
23534
dsac Basic And Diluted Weighted Average Shares Outstanding Non Redeemable Common Stock In Shares
BasicAndDilutedWeightedAverageSharesOutstandingNonRedeemableCommonStockInShares
7301760
CY2021Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.27
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23534
dsac Changes In Value Of Ordinary Shares Subject To Possible Redemption
ChangesInValueOfOrdinarySharesSubjectToPossibleRedemption
1961461
dsac Condition For Future Business Combination Number Of Businesses Minimum
ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum
1
dsac Minimum Percentage Of Trust Account Required For Business Combination
MinimumPercentageOfTrustAccountRequiredForBusinessCombination
0.80
dsac Basic And Diluted Net Income Per Share Ordinary Shares Subject To Redemptions
BasicAndDilutedNetIncomePerShareOrdinarySharesSubjectToRedemptions
0.00
CY2021Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7128582
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7301760
CY2021Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.27
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.74
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
5000002
CY2021Q1 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
3500150
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
3500152
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
5000004
CY2021Q2 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
1961461
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
1961467
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
5000010
us-gaap Net Income Loss
NetIncomeLoss
5461619
us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
88206
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-7695000
us-gaap Investment Income Interest
InvestmentIncomeInterest
51448
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-254347
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1679693
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
138257
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-124326
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
323486
us-gaap Repayments Of Debt
RepaymentsOfDebt
175626
dsac Trust Account Description
TrustAccountDescription
In connection with the redemption of 100% of the Company’s outstanding Public Shares for a portion of the funds held in the Trust Account, each holder will receive a full pro rata portion of the amount then in the Trust Account, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay the Company’s taxes payable (less up to $100,000 of interest to pay dissolution expenses).
CY2021Q2 us-gaap Cash
Cash
24000
CY2021Q2 dsac Working Capital Deficit
WorkingCapitalDeficit
1400000
dsac Contribution Of From The Sponsor To Cover Certain Expenses
ContributionOfFromTheSponsorToCoverCertainExpenses
25000
dsac Loan Amount From Sponsor
LoanAmountFromSponsor
176000
us-gaap Affiliate Costs
AffiliateCosts
2000000.0
dsac Aggregate Expenses
AggregateExpenses
1600000
CY2021Q2 dsac Working Capital Loans
WorkingCapitalLoans
0
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.74
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The preparation of the unaudited condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p>
dsac Investments Maximum Maturity Term
InvestmentsMaximumMaturityTerm
P185D
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Concentration of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000, and investments held in the Trust Account. At June 30, 2021 and December 31, 2020, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</p>
CY2021Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
dsac Underwriting Discount Per Unit
UnderwritingDiscountPerUnit
0.20
CY2021Q2 dsac Deferred Underwriting Fees Amount Payable
DeferredUnderwritingFeesAmountPayable
3500000
CY2021Q2 dsac Net Income Attributable
NetIncomeAttributable
5061
dsac Net Income Attributable
NetIncomeAttributable
43922
CY2021Q2 dsac Basic And Diluted Weighted Average Shares Outstanding Shares
BasicAndDilutedWeightedAverageSharesOutstandingShares
14746418
dsac Basic And Diluted Weighted Average Shares Outstanding Shares
BasicAndDilutedWeightedAverageSharesOutstandingShares
14573240
CY2021Q2 dsac Basic And Diluted Net Income Per Share
BasicAndDilutedNetIncomePerShare
0.00
dsac Basic And Diluted Net Income Per Share
BasicAndDilutedNetIncomePerShare
0.00
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
1961467
us-gaap Net Income Loss
NetIncomeLoss
5461619
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021Q2 us-gaap Interest And Dividend Income Securities Other
InterestAndDividendIncomeSecuritiesOther
5061
us-gaap Interest And Dividend Income Securities Other
InterestAndDividendIncomeSecuritiesOther
43922
CY2020Q3 dsac Sponsor Agreed Description
SponsorAgreedDescription
The Sponsor agreed to surrender for no consideration 656,250 founder shares when the option to purchase additional units was not exercised by the underwriters.
dsac Additional Unit Per Shares
AdditionalUnitPerShares
0.35
CY2021Q2 us-gaap Due From Affiliate Noncurrent
DueFromAffiliateNoncurrent
0
CY2020Q4 dsac Deferred Underwriting Fees Payable Non Current
DeferredUnderwritingFeesPayableNonCurrent
6100000
CY2020Q4 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
17500000
CY2020Q4 us-gaap Due From Affiliate Noncurrent
DueFromAffiliateNoncurrent
2000000.0
CY2021Q2 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
0
CY2020Q4 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
1600000
dsac Working Capital Loan Amount
WorkingCapitalLoanAmount
1500000
dsac Price Per Share Warrants
PricePerShareWarrants
1.00
CY2021Q2 dsac Maximum Number Of Demands For Registration Of Securities
MaximumNumberOfDemandsForRegistrationOfSecurities
3
CY2021Q2 dsac Aggregate Deferred Underwriting Commission
AggregateDeferredUnderwritingCommission
6100000
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
dsac Threshold Conversion Ratio Of Stock
ThresholdConversionRatioOfStock
1
dsac Warrants And Rights Outstanding Exercisable Term From Closing Of Business Combination
WarrantsAndRightsOutstandingExercisableTermFromClosingOfBusinessCombination
P30D
dsac Warrants And Rights Outstanding Exercisable Term From Closing Of Initial Public Offering
WarrantsAndRightsOutstandingExercisableTermFromClosingOfInitialPublicOffering
P12M
dsac Maximum Thres Hold Period For Filing Registration Statement After Business Combination
MaximumThresHoldPeriodForFilingRegistrationStatementAfterBusinessCombination
P15D
CY2021Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.50
CY2021Q2 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
dsac Threshold Issue Price For Capital Raising Purposes In Connection With Closing Of Business Combination
ThresholdIssuePriceForCapitalRaisingPurposesInConnectionWithClosingOfBusinessCombination
9.20
dsac Percentage Of Gross Proceeds On Total Equity Proceeds
PercentageOfGrossProceedsOnTotalEquityProceeds
0.60
dsac Threshold Trading Days For Calculating Market Value
ThresholdTradingDaysForCalculatingMarketValue
20
dsac Threshold Issue Price For Capital Raising Purposes In Connection With Closing Of Business Combination
ThresholdIssuePriceForCapitalRaisingPurposesInConnectionWithClosingOfBusinessCombination
9.20
dsac Class Of Warrant Or Right Adjustment Of Exercise Price Of Warrants Or Rights Percent Based On Market Value And Newly Issued Price
ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice
1.15
dsac Class Of Warrant Or Right Adjustment Of Redemption Price Of Warrants Or Rights Percent Based On Market Value And Newly Issued Price1
ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1
1
dsac Class Of Warrant Or Right Adjustment Of Redemption Price Of Warrants Or Rights Percent Based On Market Value And Newly Issued Price2
ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice2
1.80
dsac Common Stock Trading Days On Which Fair Market Value Of Shares Is Reported
CommonStockTradingDaysOnWhichFairMarketValueOfSharesIsReported
10
dsac Multiplier Used In Calculating Warrant Exercise Price
MultiplierUsedInCalculatingWarrantExercisePrice
0.361
CY2021Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
175082137
CY2020Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
175030689
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0

Files In Submission

Name View Source Status
0001104659-21-108647-index-headers.html Edgar Link pending
0001104659-21-108647-index.html Edgar Link pending
0001104659-21-108647.txt Edgar Link pending
0001104659-21-108647-xbrl.zip Edgar Link pending
dsac-20210630.xsd Edgar Link pending
dsac-20210630x10q.htm Edgar Link pending
dsac-20210630x10q_htm.xml Edgar Link completed
dsac-20210630xex31d1.htm Edgar Link pending
dsac-20210630xex31d2.htm Edgar Link pending
dsac-20210630xex32d1.htm Edgar Link pending
dsac-20210630xex32d2.htm Edgar Link pending
dsac-20210630_cal.xml Edgar Link unprocessable
dsac-20210630_def.xml Edgar Link unprocessable
dsac-20210630_lab.xml Edgar Link unprocessable
dsac-20210630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending